Catheter Precision (VTAK) Income from Non-Controlling Interests (2025 - 2026)
Catheter Precision's (VTAK) quarterly Income from Non-Controlling Interests came in at -$9000.0 in Q1 2026, up 87.14% on a QoQ basis from -$70000.0 in Q4 2025.
Catheter Precision (VTAK) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends
Catheter Precision (VTAK) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$9000.0 in Q1 2026.
- On a quarterly basis, Income from Non-Controlling Interests changed N/A year-over-year to -$9000.0 in Q1 2026; TTM through Mar 2026 was -$521000.0, a N/A change from a year earlier, with the FY2025 full-year figure at -$512000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests for Q1 2026 stood at -$9000.0, up from -$70000.0 in the prior quarter.
- Over the last five years, Income from Non-Controlling Interests for VTAK reached as high as -$9000.0 in Q1 2026 and fell as low as -$349000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 22.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -5.85 Mn |
| 10 | Catheter Precision | 635,411.82 | 235,411.82 | 390,000.00 | -9,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -349,000.00 |